Cargando…
In silico screening of potent bioactive compounds from honeybee products against COVID-19 target enzymes
After the early advent of the Coronavirus Disease 2019 (COVID-19) pandemic, myriads of FDA-approved drugs have been massively repurposed for COVID-19 treatment based on molecular docking against selected protein targets that play fundamental roles in the replication cycle of the novel coronavirus. H...
Autores principales: | Shaldam, Moataz A., Yahya, Galal, Mohamed, Nashwa H., Abdel-Daim, Mohamed M., Al Naggar, Yahya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088405/ https://www.ncbi.nlm.nih.gov/pubmed/33934306 http://dx.doi.org/10.1007/s11356-021-14195-9 |
Ejemplares similares
-
Engineered nanomaterials as fighters against SARS-CoV-2: The way to control and treat pandemics
por: Abd Elkodous, Mohamed, et al.
Publicado: (2020) -
The COVID-19 pandemic: prediction study based on machine learning models
por: Malki, Zohair, et al.
Publicado: (2021) -
COVID-19: a new emerging respiratory disease from the neurological perspective
por: El-Sayed, Amr, et al.
Publicado: (2021) -
COVID-19 and beliefs about tobacco use: an online cross-sectional study in Iran
por: Kalan, Mohammad Ebrahimi, et al.
Publicado: (2020) -
Air pollution particulate matter as a potential carrier of SARS-CoV-2 to the nervous system and/or neurological symptom enhancer: arguments in favor
por: Borisova, Tatiana, et al.
Publicado: (2020)